TABLE 1.
Neutralizing antibody titers in response to scSIV immunization
Wk (sample) | 50% Neutralization titer for strain and macaque no.a:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mm 12-94b
|
Mm 169-84b
|
Mm 245-91b
|
Mm 415-90b
|
|||||||||
239 | 316 | 251LA | 239 | 316 | 251LA | 239 | 316 | 251LA | 239 | 316 | 251LA | |
0 (1st dose) | — | NT | — | — | NT | — | — | NT | — | — | NT | — |
8 (2nd dose) | — | NT | — | — | NT | — | — | NT | — | — | NT | — |
11 | — | NT | — | — | NT | 160 | — | NT | 20 | — | NT | 20 |
33 (3rd dose) | — | NT | — | — | NT | — | — | NT | — | — | NT | — |
35 | — | 60 | 240 | — | 40 | 320 | — | 80 | 160 | — | 60 | 320 |
39 (challenge) | — | 30 | 80 | — | 80 | 120 | — | 40 | 60 | — | 60 | 80 |
Neutralizing antibody titers indicate the reciprocal of the plasma dilution that reduced SIV infection of CEMx174SIV-SEAP cells containing a Tat-inducible SEAP reporter construct by 50%. Antibody neutralization was tested against SIVmac239 (239), SIVmac316 (316), and a lab-adapted strain of SIVmac251 (251LA). Samples that were negative for virus neutralization at the lowest dilution tested (<1:20) are indicate by a dash (—). Time points that were not tested for neutralization of SIVmac316 are indicated by NT. Two different pools of positive-control plasma from SIV-infected rhesus macaques gave titers of 3,840 and 10,240 against lab-adapted SIVmac251, 2,560 against SIVmac316, and 20 and 70 against SIVmac239. Negative-control pools from uninfected animals were unable to neutralize either SIVmac251 or SIVmac239.
Mm 12-94, Mm 169-84, Mm 245-91, and Mm 415-90 were immunized with scSIVmac239Nefsff and scSIVmac316Nefsff at weeks 0, 8, and 33.